Medifast declares $1.64 quarterly dividend, reelects directors, and amends executive severance plan

MEDIFAST INC

Stockholders elected seven directors to Medifast's board, each receiving over 8.8 million votes for.
Stockholders ratified RSM US LLP as independent auditor for 2022 with over 10 million votes in favor.
Non-binding advisory vote on executive compensation passed with 8.6 million votes for.
Board amended Executive Severance Plan, increasing severance multiples to 1.5x salary (2.5x for CEO) plus target bonus on change in control.
Declared $1.64 per share quarterly dividend payable on August 8, 2022 to shareholders of record June 28, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.